Developer docs
API playgroundTry for free, no card

Search company profiles

Thesis

Full company profile

uuid0000nck

Namestring
Thesis
Legal namestring
Outliers, Inc.
Websiteurl
takethesis.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Thesis (legal entity Outliers, Inc.) is a direct-to-consumer personalized nootropics company headquartered in New York that sells four cognitive performance supplements—Clarity, Motivation, Stress Reset, and Neuroprotection—matched to individual customers through an online quiz-based personalization system. The company's proprietary formula finder is described as applying deep learning across a corpus of 7.3M+ customer data points, 700+ peer-reviewed studies, 127+ tested ingredients, and 30+ ongoing beta tests, with formulations developed in collaboration with academic partners at Stanford's Wu Tsai Neurosciences Institute, MIT's Department of Brain and Cognitive Sciences, and the University of Chicago Neuroscience Institute. Products are standardized at 4x industry dose levels and feature isolated, plant-derived compounds.

Short descriptiontext

Thesis is a direct-to-consumer nootropics company offering four personalized cognitive performance supplements (Clarity, Motivation, Stress Reset, Neuroprotection) matched via a quiz-based system, serving individuals seeking focus, motivation, and stress support.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
nootropic supplements, cognitive enhancement, brain health supplements, personalized vitamins, focus supplements
Industry1 code
PRIMARYEDAFADAL
Portfolio, Performance & Rubric-Based Assessment Platforms
Education/Education Technology (EdTech) & Digital Learning/Assessment, Testing, Proctoring & Credentialing Platforms
NAICS code2 codes
  • Software Publishers5132
  • Newspaper, Periodical, Book, and Directory Publishers5131
SIC code2 codes
  • Books: Publishing Or Publishing & Printing2731
  • Periodicals: Publishing Or Publishing & Printing2721
Product category
Nootropic Dietary Supplements
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Subscription Revenue
TypeSubscription Recurring
Description

Recurring monthly subscription model with auto-renewal. Customers receive repeat deliveries based on selected frequency. First month offered at 50% discount ($59), then $79/month. Subscribers can reschedule, skip, or cancel anytime.

takethesis.com
2One-Time Purchase
TypeOne Time License
Description

Single bottle purchase option at $129 for 50 capsules. Provides an alternative to subscription for customers wanting to try the product without commitment.

takethesis.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Supply Chain, Marketing or Sales, Personnel, Operations
Pricing details3 tiers
1Monthly Subscription - First Month
ModelSubscriptionBilling cadenceMonthly
Notes

$59 for first month (50% off regular price). Includes free shipping every 25 days. Auto-renews at $79/month after first month.

takethesis.com
2Monthly Subscription - Regular
ModelSubscriptionBilling cadenceMonthly
Notes

$79/month subscription with free shipping every 25 days. Can reschedule, skip, or cancel anytime.

takethesis.com
3One-Time Purchase
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$129 for 50 capsules (one month supply). Includes 30-day money-back guarantee and free shipping.

takethesis.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Thesis is a direct-to-consumer nootropic company that sells four personalized brain-supplement formulas (Clarity, Motivation, Stress Reset, Neuroprotection). Customers complete a cognitive assessment quiz that maps their goals to a recommended formula, then receive a 50-capsule monthly bottle on subscription or via one-time purchase. The company brands and markets these supplements under its own Thesis label.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 83% of people felt more focused within 30 days of taking Clarity
+5 more records
Product overview1 text field

Thesis is a direct-to-consumer nootropic company offering four personalized cognitive performance products: Clarity, Motivation, Stress Reset, and Neuroprotection. Customers take a quiz to get matched with personalized formulas, and products are available via subscription ($59/month). The company uses a data-driven approach with clinically studied ingredients and proprietary formulations tested through thousands of customer trials.

Product and service4 records
1Clarity
CategoryNootropic Supplement
Description

A nootropic supplement designed to promote neuroplasticity, support growth of new neural connections, and enhance concentration and focus. Targeted at individual consumers seeking productivity and focus support. Sold as a 50-capsule monthly bottle via subscription ($59 first month, $79/month thereafter) or one-time purchase ($129).

2Motivation
CategoryNootropic Supplement
Description

A nootropic supplement designed to optimize dopamine signaling and balance neurotransmitters, keeping the brain energized and heightening awareness. For individual consumers seeking energy and productivity. Sold as a 50-capsule monthly bottle via subscription or one-time purchase.

3Stress Reset
CategoryNootropic Supplement
Description

A nootropic supplement designed to maintain healthy cortisol levels and optimize neurotransmitter activity, supporting a calm and resilient mind. For individual consumers experiencing stress or seeking balance. Sold as a 50-capsule monthly bottle via subscription or one-time purchase.

4Neuroprotection
CategoryNootropic Supplement
Description

A nootropic supplement designed to activate the NRF2 antioxidant pathway, strengthen mitochondrial resilience, protect neurons, sharpen memory, and support long-term brain health. For individual consumers focused on memory, learning, and aging-related cognitive support. Sold as a 50-capsule monthly bottle via subscription or one-time purchase.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Wu Tsai Neurosciences Institute at Stanford University
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partner contributing to the scientific foundation of Thesis's quiz and formulation process. Their neuroscience expertise informs the company's data-driven approach to cognitive enhancement.

takethesis.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partner providing neuroscience research insights that power the 5,000+ research hours backing Thesis's personalized cognitive assessment quiz.

3The University of Chicago Neuroscience Institute
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partner contributing neuroscience expertise to Thesis's formulation science and personalized recommendation algorithms.

takethesis.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the closest direct competitors in the universal nootropics category, offering a single multi-ingredient 'universal' formula marketed for focus, memory, and mood. Highly comparable to Thesis's Clarity on positioning, audience (biohackers and professionals), and premium subscription pricing.

TypeDirect peer
Description

Direct nootropics peer selling premium, multi-ingredient cognitive stacks (Qualia Mind, Qualia Focus) with a strong science-forward brand and DTC subscription model. Targets the same biohacker and high-performance professional audience with comparable price points and formulation philosophy.

TypeDirect peer
Description

Onnit's Alpha Brain is one of the most recognized nootropic brands in the US, sold via DTC and Amazon. Comparable target customer (performance-oriented adults) and overlapping category, though Onnit's portfolio extends across fitness supplements and equipment.

TypeDirect peer
Description

Premium nootropics and recovery supplements marketed to elite athletes and high-performers with a science-led brand. Direct overlap with Thesis on the professionals/biohackers segment and on positioning around clinical validation and partnerships with research institutions.

5Care/of
TypeEmerging player
Description

Pioneer of personalized DTC vitamins using a quiz-based recommendation engine and monthly subscription model. Highly comparable on the personalization-plus-subscription playbook even though the product category (general vitamins) is adjacent to nootropics.

TypeEmerging player
Description

DTC essential vitamins brand with a science-led, minimalist brand identity targeting health-conscious professionals. Comparable on positioning, audience, and DTC subscription mechanics, though Ritual focuses on daily foundational vitamins rather than cognitive performance.

7Athletic Greens (AG1)
TypeBroad incumbent
Description

Premium daily nutrition greens powder sold via DTC subscription at a comparable premium price point to Thesis. Targets the same health-optimizing consumer with a broader, non-cognitive wellness claim set; competes for the same subscription wallet share.

TypeEmerging player
Description

DTC adaptogen and 'superstacker' supplements brand marketing to wellness-oriented, predominantly female consumers. Comparable DTC subscription model and premium positioning, with overlapping stress/mood and brain-health benefit claims.

TypeBroad incumbent
Description

Large-scale DTC telehealth and wellness brand offering subscription-based health products including supplements and mental wellness offerings. Comparable on DTC scale, subscription mechanics, and consumer marketing sophistication, though the portfolio is much broader than nootropics.

TypeDirect peer
Description

Specialty retailer of nootropic compounds and bulk ingredients serving experienced biohackers. Overlaps directly on product category and audience, though the model is e-commerce catalog rather than personalized quiz-based subscriptions.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Thesis

Nootropic Dietary Supplementstakethesis.com

Thesis is a direct-to-consumer nootropics company offering four personalized cognitive performance supplements (Clarity, Motivation, Stress Reset, Neuroprotection) matched via a quiz-based system, serving individuals seeking focus, motivation, and stress support.

What Thesis does

Thesis (legal entity Outliers, Inc.) is a direct-to-consumer personalized nootropics company headquartered in New York that sells four cognitive performance supplements—Clarity, Motivation, Stress Reset, and Neuroprotection—matched to individual customers through an online quiz-based personalization system. The company's proprietary formula finder is described as applying deep learning across a corpus of 7.3M+ customer data points, 700+ peer-reviewed studies, 127+ tested ingredients, and 30+ ongoing beta tests, with formulations developed in collaboration with academic partners at Stanford's Wu Tsai Neurosciences Institute, MIT's Department of Brain and Cognitive Sciences, and the University of Chicago Neuroscience Institute. Products are standardized at 4x industry dose levels and feature isolated, plant-derived compounds.

Thesis firmographics

Firmographics
Name
Thesis
Legal name
Outliers, Inc.
Website
https://takethesis.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
51–100 employees
Short description
Thesis is a direct-to-consumer nootropics company offering four personalized cognitive performance supplements (Clarity, Motivation, Stress Reset, Neuroprotection) matched via a quiz-based system, serving individuals seeking focus, motivation, and stress support.
Ownership category
akta.pro rank

Thesis industry classification

Industry
Product category
Nootropic Dietary Supplements
NAICS
Software Publishers (5132), Newspaper, Periodical, Book, and Directory Publishers (5131)
SIC
Books: Publishing Or Publishing & Printing (2731), Periodicals: Publishing Or Publishing & Printing (2721)
akta.pro industry
PRIMARYEDAFADAL
Portfolio, Performance & Rubric-Based Assessment Platforms
Education/Education Technology (EdTech) & Digital Learning/Assessment, Testing, Proctoring & Credentialing Platforms

Keywords

  • Nootropic supplements
  • Cognitive enhancement
  • Brain health supplements
  • Personalized vitamins
  • Focus supplements

Where Thesis is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Thesis business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Marketing or Sales, Personnel, Operations

Revenue model

  1. Subscription Revenue: Recurring monthly subscription model with auto-renewal. Customers receive repeat deliveries based on selected frequency. First month offered at 50% discount ($59), then $79/month. Subscribers can reschedule, skip, or cancel anytime.
  2. One-Time Purchase: Single bottle purchase option at $129 for 50 capsules. Provides an alternative to subscription for customers wanting to try the product without commitment.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyMonthly Subscription - First Month
SubscriptionMonthlyMonthly Subscription - Regular
One time/ perpetual licensePay-as-you-goOne-Time Purchase

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Thesis product offering

Product offering

Core offering

Thesis is a direct-to-consumer nootropic company that sells four personalized brain-supplement formulas (Clarity, Motivation, Stress Reset, Neuroprotection). Customers complete a cognitive assessment quiz that maps their goals to a recommended formula, then receive a 50-capsule monthly bottle on subscription or via one-time purchase. The company brands and markets these supplements under its own Thesis label.

Product overview

Thesis is a direct-to-consumer nootropic company offering four personalized cognitive performance products: Clarity, Motivation, Stress Reset, and Neuroprotection. Customers take a quiz to get matched with personalized formulas, and products are available via subscription ($59/month). The company uses a data-driven approach with clinically studied ingredients and proprietary formulations tested through thousands of customer trials.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clarity A nootropic supplement designed to promote neuroplasticity, support growth of new neural connections, and enhance concentration and focus. Targeted at individual consumers seeking productivity and focus support. Sold as a 50-capsule monthly bottle via subscription ($59 first month, $79/month thereafter) or one-time purchase ($129).
  • Motivation A nootropic supplement designed to optimize dopamine signaling and balance neurotransmitters, keeping the brain energized and heightening awareness. For individual consumers seeking energy and productivity. Sold as a 50-capsule monthly bottle via subscription or one-time purchase.
  • Stress Reset A nootropic supplement designed to maintain healthy cortisol levels and optimize neurotransmitter activity, supporting a calm and resilient mind. For individual consumers experiencing stress or seeking balance. Sold as a 50-capsule monthly bottle via subscription or one-time purchase.
  • Neuroprotection A nootropic supplement designed to activate the NRF2 antioxidant pathway, strengthen mitochondrial resilience, protect neurons, sharpen memory, and support long-term brain health. For individual consumers focused on memory, learning, and aging-related cognitive support. Sold as a 50-capsule monthly bottle via subscription or one-time purchase.

Quantifiable outcome

  • 83% of people felt more focused within 30 days of taking Clarity
  • +5 more outcomes

Companies that use Thesis

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Thesis technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Thesis partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Wu Tsai Neurosciences Institute at Stanford UniversitycoreStrategic or Co-development PartnerAcademic research partner contributing to the scientific foundation of Thesis's quiz and formulation process. Their neuroscience expertise informs the company's data-driven approach to cognitive enhancement.
  • MIT Brain and Cognitive SciencescoreStrategic or Co-development PartnerAcademic partner providing neuroscience research insights that power the 5,000+ research hours backing Thesis's personalized cognitive assessment quiz.
  • The University of Chicago Neuroscience InstitutecoreStrategic or Co-development PartnerResearch partner contributing neuroscience expertise to Thesis's formulation science and personalized recommendation algorithms.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Thesis competitors and assessment

Company assessment

Direct peers

  • Mind Lab Pro: One of the closest direct competitors in the universal nootropics category, offering a single multi-ingredient 'universal' formula marketed for focus, memory, and mood. Highly comparable to Thesis's Clarity on positioning, audience (biohackers and professionals), and premium subscription pricing.
  • Neurohacker Collective (Qualia): Direct nootropics peer selling premium, multi-ingredient cognitive stacks (Qualia Mind, Qualia Focus) with a strong science-forward brand and DTC subscription model. Targets the same biohacker and high-performance professional audience with comparable price points and formulation philosophy.
  • Onnit (Alpha Brain): Onnit's Alpha Brain is one of the most recognized nootropic brands in the US, sold via DTC and Amazon. Comparable target customer (performance-oriented adults) and overlapping category, though Onnit's portfolio extends across fitness supplements and equipment.
  • Momentous: Premium nootropics and recovery supplements marketed to elite athletes and high-performers with a science-led brand. Direct overlap with Thesis on the professionals/biohackers segment and on positioning around clinical validation and partnerships with research institutions.
  • Nootropics Depot: Specialty retailer of nootropic compounds and bulk ingredients serving experienced biohackers. Overlaps directly on product category and audience, though the model is e-commerce catalog rather than personalized quiz-based subscriptions.

Emerging players

  • Care/of: Pioneer of personalized DTC vitamins using a quiz-based recommendation engine and monthly subscription model. Highly comparable on the personalization-plus-subscription playbook even though the product category (general vitamins) is adjacent to nootropics.
  • Ritual: DTC essential vitamins brand with a science-led, minimalist brand identity targeting health-conscious professionals. Comparable on positioning, audience, and DTC subscription mechanics, though Ritual focuses on daily foundational vitamins rather than cognitive performance.
  • Moon Juice: DTC adaptogen and 'superstacker' supplements brand marketing to wellness-oriented, predominantly female consumers. Comparable DTC subscription model and premium positioning, with overlapping stress/mood and brain-health benefit claims.

Broad incumbents

  • Athletic Greens (AG1): Premium daily nutrition greens powder sold via DTC subscription at a comparable premium price point to Thesis. Targets the same health-optimizing consumer with a broader, non-cognitive wellness claim set; competes for the same subscription wallet share.
  • Hims & Hers: Large-scale DTC telehealth and wellness brand offering subscription-based health products including supplements and mental wellness offerings. Comparable on DTC scale, subscription mechanics, and consumer marketing sophistication, though the portfolio is much broader than nootropics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Thesis social profiles

Digital presence

Thesis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Thesis leadership team

Management profile

Number of profiles

Profiles2 records

Thesis funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Thesis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Thesis

What does Thesis do?

Thesis is a direct-to-consumer nootropic company that sells four personalized brain-supplement formulas (Clarity, Motivation, Stress Reset, Neuroprotection). Customers complete a cognitive assessment quiz that maps their goals to a recommended formula, then receive a 50-capsule monthly bottle on subscription or via one-time purchase. The company brands and markets these supplements under its own Thesis label.

Is Thesis a public or private company?

Thesis is a private company. It is classified as venture growth investor backed and is currently operating.

When was Thesis founded?

Thesis was founded in 2017. It employs 51 to 100 people.

Where is Thesis based?

Thesis is headquartered in New York, United States, in the North America region.

How does Thesis make money?

Two revenue lines are on record. Subscription Revenue is the primary driver. The others are one-Time Purchase.

Who are Thesis's main competitors?

Direct peers on record are Mind Lab Pro, Neurohacker Collective (Qualia), Onnit (Alpha Brain), Momentous and Nootropics Depot. Emerging players are Care/of, Ritual and Moon Juice. Broad incumbents are Athletic Greens (AG1) and Hims & Hers.

Does Thesis have an API?

No public API is recorded for Thesis.

What industry is Thesis in?

Thesis's product category is Nootropic Dietary Supplements. Its primary akta.pro industry code is EDAFADAL, Portfolio, Performance & Rubric-Based Assessment Platforms. Its NAICS code is 5132 and its SIC code is 2731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TechRoundThe Top 10 Nootropic Startups Powering The Next Wave Of Cognitive TechGrand View Research reported that the UK nootropics market generated $187.2 million in 2025 and is projected to reach $478.1 million by 2033, with annual growth of 12.7% from 2026 onwards, as consumer demand shifts toward legal, daily-use cognitive support supplements in convenient formats. The article profiles 10 startups innovating in the space: Unconform, Spacegoods, Neutonic, Nootro Labs, British VitaTech, Heights, Thesis, Mind Lab Pro, HVMN, and Neurohacker Collective. These companies are developing products ranging from performance drinks and mushroom-based beverages to flavoured toothpicks, personalized blends, and premium nootropic formulas, targeting professionals, students, and biohackers seeking cognitive enhancement without prescription requirements.ForbesI Tried Thesis Nootropics—Here’s My Honest ReviewThe author reviews Thesis Nootropics, a nootropic supplement company, and reports that the Clarity blend significantly improved focus and productivity, while the Motivation blend caused heartburn. The blends cost $129 each, with subscriptions at $79 per month, and the author plans to use the product again.The Jerusalem PostThesis Supplements: 2024 Review of These Cognitive EnhancersThesis supplements are personalized nootropics offering six blends for focus, memory, and creativity. The company, founded by Dan Freed in 2017, uses ingredients like alpha GPC and lion's mane, with subscription pricing at $79 per month. User reviews report mixed results, with some noting improved focus and others citing side effects like anxiety.EscapecollectiveTech gallery: 2024 Sea Otter Classic, part twoThe 2024 Sea Otter Classic showcased numerous new innovations in biking gear, with significant contributions from companies such as Praxis, Vittoria, Maxxis, Thesis, and Stan’s NoTubes. Key highlights included Praxis's new carbon fiber crankset and Vittoria's eco-friendly gravel tires made from renewable materials. This event demonstrates ongoing advancements in cycling technology and materials, appealing to both competitive and recreational cyclists.Hone HealthThesis Nootropics Review (2025): Do The Brain Boosters Actually Work?Hone Health editors conducted a three-month review of Thesis nootropics, evaluating the company's personalized supplement blends for cognitive enhancement. The analysis highlights Thesis's high-quality ingredients and responsive customer service as key strengths, while noting the products are expensive and results vary significantly between individuals. The reviewers concluded that Thesis serves as a viable entry point for those new to nootropics who wish to avoid extensive research.Hone HealthThesis Nootropics Review (2024): Do The Brain Boosters Actually Work?Thesis nootropics are a subscription service offering personalized brain-boosting blends, with each box containing four weekly blends. The service costs $79 per month, and user reviews report mixed results, with some blends effective for creativity while others cause anxiety. The review concludes Thesis is a good entry point for nootropic users.Pulse 2.0Thesis: $13.5 Million Raised For Customized Approaches To Cognitive Performance ProductsThesis, a company specializing in customized cognitive performance products, announced it has raised over $13.5 million in funding through a Series A round and previous seed investments. The capital will be used to support executive hiring, expand product selection, and conduct clinical trials for its brain chemistry-based formulations.Venture Capital Access OnlineThesis, the First High Quality and Customized Nootropics Solution, Raises Total of $13.5 Million in FundingThesis, a customized nootropics company, announced the closing of an $8.4 million Series A funding round, bringing its total capital raised to $13.5 million. The investment was led by Unilever Ventures and included participation from Redo Ventures, Alive VC, Break Trail, and individual investors Kevin Love and Kate Bock. The newly raised capital will be used for executive hires, product expansion, and clinical trials.VC News DailyThesis Announces $13.5M Seed and Series AThesis, a company that develops cognitive performance products based on individual brain chemistry, raised over $13.5 million in total funding through a Series A round of $8.4 million and a seed round of $5.1 million. Investors in the latest funding include Unilever Ventures, Redo Ventures, Alive VC, and others, indicating strong interest in customized cognitive solutions. The funding will support Thesis's development of targeted nutrient compounds for enhancing mental performance.